tiprankstipranks
Verona Pharma Plc (VRNA)
NASDAQ:VRNA
US Market

Verona Pharma (VRNA) Technical Analysis

Compare
743 Followers

Technical Sentiment

Overall Consensus
Strong Buy
14Bullish
6Neutral
2Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Verona Pharma Plc’s (VRNA) Moving Averages Convergence Divergence (MACD) indicator is 1.39, suggesting Verona Pharma Plc is a Buy.
Verona Pharma Plc’s (VRNA) 20-Day exponential moving average is 64.98, while Verona Pharma Plc’s (VRNA) share price is $66.18, making it a Buy.
Verona Pharma Plc’s (VRNA) 50-Day exponential moving average is 60.40, while Verona Pharma Plc’s (VRNA) share price is $66.18, making it a Buy.

Verona Pharma (VRNA) Pivot Points

Mar 27, 2025, 08:36 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
61.09
62.44
64.61
65.96
68.13
69.48
71.65
Fibonacci
62.44
63.78
64.62
65.96
67.30
68.14
69.48
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verona Pharma (VRNA) Moving Averages

Mar 27, 2025, 08:36 AM
Period
Simple
Exponential
MA5
66.43Sell
66.17Buy
MA10
65.66Buy
65.77Buy
MA20
65.61Buy
64.98Buy
MA50
61.07Buy
60.40Buy
MA100
50.79Buy
52.57Buy
MA200
37.72Buy
40.12Buy
Verona Pharma Plc’s (VRNA) 10-Day exponential moving average is 65.77, while Verona Pharma Plc’s (VRNA) share price is $66.18, making it a Buy.
Verona Pharma Plc’s (VRNA) 100-Day exponential moving average is 52.57, while Verona Pharma Plc’s (VRNA) share price is $66.18, making it a Buy.
Verona Pharma Plc’s (VRNA) stock price is $66.18 and Verona Pharma Plc’s (VRNA) 50-day simple moving average is 61.07, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $66.18 and Verona Pharma Plc’s (VRNA) 100-day simple moving average is 50.79, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $66.18 and Verona Pharma Plc’s (VRNA) 200-day simple moving average is 37.72, creating a Buy signal.

Verona Pharma (VRNA) Technical Indicators

Mar 27, 2025, 08:36 AM
Name
Value
Implied Action
RSI (14)
54.20
Neutral
STOCH (9,6)
75.10
Neutral
STOCHRSI (14)
69.37
Neutral
MACD (12,26)
1.39
Buy
ADX (14)
25.83
Neutral
Williams %R
-32.18
Buy
CCI (14)
23.67
Neutral
ATR (14)
3.42
-
Ultimate Oscillator
63.36
Neutral
ROC
-1.87
Sell
Verona Pharma Plc’s (VRNA) Relative Strength Index (RSI) is 54.20, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Trend Strength Indicator (ADX) is 25.83, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Commodity Channel Index (CCI) is 23.67, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Price Rate of Change (ROC) is -1.87, creating a Sell signal.

FAQ

Is VRNA a Buy, Hold, or Sell?
Based on VRNA’s technical indicators, VRNA is a Strong Buy.
    What is VRNA’s RSI (14)?
    VRNA’s RSI (14) is 54.20, which suggests VRNA is a Neutral.
      What is VRNA’s MACD?
      VRNA’s MACD is 1.39, which suggests VRNA is a Buy.
        What is VRNA’s 5-day moving average?
        VRNA’s 5-day moving average is 66.43, which suggests VRNA is a Sell.
          What is VRNA’s 20-day moving average?
          VRNA 20-day moving average is 65.61, which suggests VRNA is a Buy.
            What is VRNA’s 50-day moving average?
            VRNA’s 50-day moving average is 61.07, which suggests VRNA is a Buy.
              What is VRNA’s 200-day moving average?
              VRNA’s 200-day moving average is 37.72, which suggests VRNA is a Buy.
                What is VRNA’s Williams % R (14)?
                VRNA’s Williams % R (14) is -32.18, which suggests VRNA is a Buy.
                  What is VRNA’s CCI (14)?
                  VRNA’s CCI (14) is 23.67, which suggests VRNA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis